Recursion to Participate in Upcoming Investor Conferences
Recursion (NASDAQ:RXRX), a clinical stage TechBio company, has announced its participation in two upcoming investor conferences in September 2025. The company will present at the Citi 2025 BioPharma Back to School Conference on September 3 and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8. Investors can access the webcasts through Recursion's investor relations website at ir.recursion.com.
Recursion (NASDAQ:RXRX), azienda TechBio in fase clinica, ha comunicato la sua partecipazione a due conferenze per investitori a settembre 2025. La società presenterà al Citi 2025 BioPharma Back to School Conference il 3 settembre e al Morgan Stanley 23rd Annual Global Healthcare Conference l'8 settembre. I webcast saranno disponibili sul sito investor relations di Recursion all'indirizzo ir.recursion.com.
Recursion (NASDAQ:RXRX), una empresa TechBio en fase clínica, ha anunciado su participación en dos conferencias para inversores en septiembre de 2025. La compañía presentará en el Citi 2025 BioPharma Back to School Conference el 3 de septiembre y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 8 de septiembre. Los webcast estarán disponibles en la web de relaciones con inversores de Recursion en ir.recursion.com.
Recursion (NASDAQ:RXRX)는 임상 단계의 테크바이오(TechBio) 기업으로, 2025년 9월에 예정된 두 건의 투자자 컨퍼런스에 참가한다고 발표했습니다. 이 회사는 9월 3일 Citi 2025 BioPharma Back to School Conference와 9월 8일 Morgan Stanley 23rd Annual Global Healthcare Conference에서 발표할 예정입니다. 웹캐스트는 Recursion의 IR 사이트 ir.recursion.com을 통해 시청할 수 있습니다.
Recursion (NASDAQ:RXRX), une société TechBio en phase clinique, a annoncé sa participation à deux conférences investisseurs en septembre 2025. La société présentera au Citi 2025 BioPharma Back to School Conference le 3 septembre et au Morgan Stanley 23rd Annual Global Healthcare Conference le 8 septembre. Les webcasts seront disponibles sur le site investisseurs de Recursion à l'adresse ir.recursion.com.
Recursion (NASDAQ:RXRX), ein klinisch fortgeschrittenes TechBio-Unternehmen, hat seine Teilnahme an zwei Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Citi 2025 BioPharma Back to School Conference am 3. September und am Morgan Stanley 23rd Annual Global Healthcare Conference am 8. September präsentieren. Webcasts sind über Recursions Investor-Relations-Website unter ir.recursion.com zugänglich.
- None.
- None.
Salt Lake City, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
- Citi 2025 BioPharma Back to School Conference — Wednesday, September 3, 2025
- Morgan Stanley 23rd Annual Global Healthcare Conference — Monday, September 8, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Investor Contact investor@recursion.com Media Contact media@recursion.com
FAQ
When is Recursion (RXRX) presenting at the Citi BioPharma Conference 2025?
When is Recursion's presentation at the Morgan Stanley Healthcare Conference 2025?
Where can I watch Recursion's (RXRX) investor conference webcasts?
What type of company is Recursion (RXRX)?
